Yoshihiro Hayashi

Yoshihiro Hayashi


Research Focus & Metrics

Academic Career Length

33Years (1994-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 February 2018 in Drug Development and Industrial Pharmacy
Verified
Journal Article
Closed access
YHYoshihiro Hayashi
Yoshihiro Hayashi
TOTakuya Oishi
Takuya Oishi
KSKaede Shirotori
Kaede Shirotori
YMYuki Marumo
Yuki Marumo
AKAtsushi Kosugi
Atsushi Kosugi
YOYoshinori Onuki
Yoshinori Onuki
Objectives: The aim of this study was to explore the potential of boosted tree (BT) to develop a correlation model between active pharmaceutical ingredient (API) characteristics and a tensile strength (TS) of tablets as critical quality attributes. Methods: First, we evaluated 81 kinds of API characteristics, such as particle size distribution, bulk density, tapped density, Hausner ratio, moisture content, elastic recovery, molecular weight, and partition coefficient. Next, we prepared tablets containing 50% API, 49% microcrystalline cellulose, and 1% magnesium stearate using direct compression at 6, 8, and 10 kN, and measured TS. Then, we applied BT to our dataset to develop a correlation model. Finally, the constructed BT model was validated using k-fold cross-validation. Results: Results showed that the BT model achieved high-performance statistics, whereas multiple regression analysis resulted in poor estimations. Sensitivity analysis of the BT model revealed that diameter of powder particles at the 10th percentile of the cumulative percentage size distribution was the most crucial factor for TS. In addition, the influences of moisture content, partition coefficients, and modal diameter were appreciably meaningful factors. Conclusions: This study demonstrates that BT model could provide comprehensive understanding of the latent structure underlying APIs and TS of tablets.

1 November 2021 in International Journal of Pharmaceutics
Verified
Journal Article
Closed access
YHYoshihiro Hayashi
Yoshihiro Hayashi
YNYuri Nakano
Yuri Nakano
YMYuki Marumo
Yuki Marumo
SKShungo Kumada
Shungo Kumada
KOKotaro Okada
Kotaro Okada
YOYoshinori Onuki
Yoshinori Onuki

18 October 2022 in International Journal of Pharmaceutics: X
Verified
Journal Article
Open access
HIHiroaki Iwata
Hiroaki Iwata
YHYoshihiro Hayashi
Yoshihiro Hayashi
AHAki Hasegawa
Aki Hasegawa
KTKei Terayama
Kei Terayama
YOYasushi Okuno
Yasushi Okuno
Convolutional Neural Networks (CNNs) are image analysis techniques that have been applied to image classification in various fields. In this study, we applied a CNN to classify scanning electron microscopy (SEM) images of pharmaceutical raw material powders to determine if a CNN can evaluate particle morphology. We tested 10 pharmaceutical excipients with widely different particle morphologies. SEM images for each excipient were acquired and divided into training, validation, and test sets. Classification models were constructed by applying transfer learning to pretrained CNN models such as VGG16 and ResNet50. The results of a 5-fold cross-validation showed that the classification accuracy of the CNN model was sufficiently high using either pretrained model and that the type of excipient could be classified with high accuracy. The results suggest that the CNN model can detect differences in particle morphology, such as particle size, shape, and surface condition. By applying Grad-CAM to the constructed CNN model, we succeeded in finding particularly important regions in the particle image of the excipients. CNNs have been found to have the potential to be applied to the identification and characterization of raw material powders for pharmaceutical development.

1 November 2020 in European Journal of Pharmaceutical Sciences
Verified
Journal Article
Closed access
KOKousuke Ougi
Kousuke Ougi
KOKotaro Okada
Kotaro Okada
KLKok Hoong Leong
Kok Hoong Leong
YHYoshihiro Hayashi
Yoshihiro Hayashi
SKShungo Kumada
Shungo Kumada
YOYoshinori Onuki
Yoshinori Onuki

1 March 2020 in International Journal of Pharmaceutics
Verified
Journal Article
Closed access
TOTakuya Oishi
Takuya Oishi
YHYoshihiro Hayashi
Yoshihiro Hayashi
MNMiho Noguchi
Miho Noguchi
FYFumiaki Yano
Fumiaki Yano
SKShungo Kumada
Shungo Kumada
YOYoshinori Onuki
Yoshinori Onuki

1 October 2017 in International Journal of Pharmaceutics
Verified
Journal Article
Closed access
YHYoshihiro Hayashi
Yoshihiro Hayashi
TTTakahiro Tsuji
Takahiro Tsuji
KSKaede Shirotori
Kaede Shirotori
TOTakuya Oishi
Takuya Oishi
AKAtsushi Kosugi
Atsushi Kosugi
YOYoshinori Onuki
Yoshinori Onuki